Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended			36 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2023
Cash flows from operating activities:
Net earnings	$ 262	$ (932)	$ 612
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:
Depreciation and amortization	692	692	783
Impairments and loss on sale of other investments	7	24	0
Impairments and (gain)/loss on disposal of assets, net	1,250	2,050	79
(Gain)/Loss on sale of equity interest in naviHealth	0	2	(2)
Loss on early extinguishment of debt	0	10	14
Share-based compensation	96	81	89
Provision for/(benefit from) deferred income taxes	(31)	7	496
Provision for bad debts	99	68	65
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(947)	(1,526)	(904)
Increase in inventories	(340)	(1,071)	(1,584)
Increase in accounts payable	2,718	3,428	2,325
Other accrued liabilities and operating items, net	(967)	293	452
Net cash provided by operating activities	2,839	3,122	2,429
Cash flows from investing activities:
Additions to property and equipment	(481)	(387)	(400)
Proceeds from divestitures, net of cash sold	0	923	0
Acquisition of subsidiaries, net of cash acquired	(10)	(22)	(3)
Proceeds from disposal of property and equipment	12	31	0
Purchase of other investments	(7)	(78)	(22)
Proceeds from sale of investments	3	29	47
Proceeds from net investment hedge terminations	29	71	0
Net cash provided by/(used in) investing activities	(454)	567	(378)
Cash flows from financing activities:
Purchase of noncontrolling interests	3	0	0
Proceeds from interest rate swap terminations	0	0	18
Reduction of long-term obligations	(579)	(885)	(570)
Net tax proceeds/(withholding) from share-based compensation	56	(19)	8
Dividends on common shares	(525)	(559)	(573)
Purchase of treasury shares	(2,000)	(1,000)	(200)
Net cash used in financing activities	(3,051)	(2,463)	(1,317)
Effect of exchange rates changes on cash and equivalents	(8)	(25)	11
Cash reclassified from/(to) assets held for sale	0	109	(109)
Net increase/(decrease) in cash and equivalents	(674)	1,310	636
Cash and equivalents at beginning of period	4,717	3,407	2,771	$ 2,771
Cash and equivalents at end of period	4,043	4,717	3,407	$ 4,043
Supplemental Information:
Cash payments for interest	203	153	182
Net cash payments/(refunds) for income taxes	$ 156	$ (766)	$ 273